JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details

449 Tue, 8/11/2015, 2:00 PM - 2:45 PM CC-4B
SPEED: Topics in Genetics and Biopharmaceutical Applications, Part 2 — Contributed Poster Presentations
Section on Statistics in Genomics and Genetics , Biometrics Section , Biopharmaceutical Section , WNAR
Chair(s): Duo Jiang, Oregon State University
1: Error Bounds of L1 Penalized Estimator for High-Dimensional Support Vector Machine Bo Peng, University of Minnesota ; Lan Wang, University of Minnesota ; Yichao Wu, North Carolina State University
2: Unified Approach to Variable Selection in Missing Data via Least Squares Approximation Eric Reyes ; Cody Roberts, Rose-Hulman Institute of Technology
3: Model Identification in Linear Fixed Effects Models Ondrej Blaha, LSU Health Sciences Center ; Julia Volaufova, LSU Health Sciences Center ; Lynn Roy LaMotte, LSU Health Sciences Center
4: Incorporating ENCODE Information into SNP-Based Phenotype Prediction Yue-Ming Chen, The University of Texas at Houston ; Peng Wei, The University of Texas School of Public Health
5: Genome-Wide Haplotypic Testing in a Finnish Cohort Identifies a Novel Association with Low-Density Lipoprotein Cholesterol Qian Zhang, University of Washington ; Sharon Browning, University of Washington ; Brian Browning, University of Washington
6: Prediction of Subcellular Locations for Fungal Proteins James Munyon, Youngstown State University ; Sepideh Khavari, Youngstown State University ; Guang-Hwa Chang, Youngstown State University ; Xiangjia Min, Youngstown State University
7: Unconditional Exact Tests for Binomial Proportions in the Group Sequential Setting Navneet Hakhu, Axio Research ; Scott Emerson, University of Washington
8: The Q-MFG Test: A Linear Mixed Effect Model to Detect Maternal-Offspring Genetic Effects Michelle M. Creek, UCLA ; Eric M. Sobel, UCLA ; Janet S. Sinsheimer, UCLA
9: Misclassification of the Strata in Stratified Randomized Clinical Trials in Diabetic Study Anjun Cao, Johnson & Johnson
11: MvGST: Multivariate and Directional Gene Set Testing John Stevens, Utah State University ; Dennis Mecham, Utah State University ; Garrett Saunders, Brigham Young University - Idaho ; S. Clay Isom, Utah State University
12: Quality-Adjusted Survival Analysis: An Application to a Phase III Randomized Study in Multiple Myeloma Suddhasatta Acharyya, Novartis Pharmaceuticals ; Ashok Panneerselvam, Novartis Pharmaceuticals ; Sofia Paul, Novartis Pharmaceuticals
13: Tail-Based Robust Test to Detect Gene Differential Expression in RNA-Seq Data Jiong Chen, MD Anderson Cancer Center ; Jianhua Hu, MD Anderson Cancer Center
14: Dose Escalation with Over-Dose and Under-Dose Control in Phase I/II Clinical Trials Zhengjia Chen, Emory University ; Ying Yuan, MD Anderson Cancer Center ; Zheng Li, Emory University ; Michael Kutner, Emory University ; Taofeek Owonikoko, Emory University ; Walter J. Curran, Emory University ; Fadlo Khuri, Emory University ; Jeanne Kowalski, Emory University
15: Tipping Point Analysis for Tolvaptan Clinical Study in Patients with ADPKD John Ouyang, Otsuka ; Junfang Li ; Matilda Hsieh, Otsuka
16: Missing Data Methods When Analyzing a Phase III Trial in an Orphan Indication Changlu Liu, Novartis ; Mark Baillie, Novartis ; Melanie Wright, Novartis ; Mouna Akacha, Novartis
17: A Simulation Study of Bias Due to Missing Longitudinal Data Katherine Kirkwood, Icahn School of Medicine at Mount Sinai ; Michael Parides, Icahn School of Medicine at Mount Sinai
18: Bayesian Semiparametric Analysis of Recurrent Events Data: Investigating Risk Factors for Cardiovascular Disease Changes Over Event History Li-An Lin, The University of Texas Health Science Center ; Sheng Luo, The University of Texas Health Science Center ; Barry R. Davis, The University of Texas Health Science Center
19: Statistics to Evaluate Biomarkers in Predicting Residual Cardiovascular Risk in a Case-Cohort Study Warren Bao, Pfizer Inc. ; Rana Fayyad, Pfizer Inc. ; Sarah Young, Pfizer Inc. ; Peter Ganz, San Francisco General Hospital/University of California
20: Model Selection for mRNA Counts Burcin Simsek, University of Pittsburgh ; Satish Iyengar, University of Pittsburgh

For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home